Study Information

What’s involved?

  • 2 days & nights inpatient stay
  • 2  follow-up phone calls

Participants in this research are reimbursed $1,000 for their time and this clinical trial has been approved by an independent ethics committee.

About the Study

Participate in a clinical study to test a potential new treatment for Atrial Fibrillation. 

This medication has been approved and used since 1985. In this study we are looking at a new method of admission – through an inhaler, instead of as a pill or intravenously. The goal is to have a faster effect, because the medication can reach the heart faster. 

 How do I find out more?

If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at quoting “Pulse Study”.

If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!

  • 2
    Nights Inpatient Stay
  • 2 follow up phone calls
    Outpatient Visits

Minimum Eligibility Requirements:

  • Healthy males and females
  • Aged 18 – 55 years old, inclusive
  • BMI 18.5 – 32.0 kg/m2
  • Weight must be over 55kg
  • Not taking prescription medications (contraception okay)
  • Non-smokers